Schedule 13D ownership disclosure
Vallon Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 92023M101
Event date: 2021-02-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 20.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-022191
- Form type
- SC 13D
- Filer
- SALMON Pharma GmbH
- CIK
- CIK 1843677
- Filed
- Feb 16, 2021
- Reporting period
- Feb 09, 2021
- Description
- Schedule 13D beneficial ownership